Morgan Roupret, MD

Morgan Roupret, MD, of Hopital Pitié-Salpétrière

Articles by Morgan Roupret, MD

Durvalumab With NAC in Patients With Operable High-Risk UTUC

Morgan Roupret, MDUpper Tract Urothelial Carcinoma | February 24, 2025

Drs. Roupret and Houede dissect their research on the safety and efficacy of durvalumab with NAC for operable high-risk UTUC.